By: Yara Abdou, MD, Date. 12/08/2023 At SABCS 2023, Yara Abdou, MD, a medical oncologist…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

By. Joanne Kotsopoulos, MD, Date: 12/07/2023 At the SABCS 2023 conference, Joanne Kotsopoulos, MD, a researcher…

Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…

Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…

By: Carol Fabian, MD Date. 12/07/2023 In an interview, Carol Fabian, MD, an expert in breast…

By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…

In an ongoing Phase 1/2 study, Constantine Tam, MD, a researcher and Professor of Haematology,…